Birgitt Schuele (She/her)

Making a difference for Parkinson's disease research. My research improves patient care by unraveling the causes of neurodegeneration. 🌈🏃🏻‍♀️🧑‍🔬

[Birgitt Schuele (She/her) @SchueleLab]

Our new Neurology Genetics paper shares preliminary evidence that ATXN10 motif architecture, not just expansion length, may influence onset in SCA10.

This is the first step. More sequencing, larger cohorts, and deeper analyses are coming.

https://t.co/wk4g3m1MRN

[Birgitt Schuele (She/her) @SchueleLab]

New preprint on ATXN10 in Peruvian families show repeat motif patterns influence disease onset @PacBio @bionano @mario_cornejo_o https://t.co/IfiazlflAz

[Birgitt Schuele (She/her) @SchueleLab]

Now it's published in the journal The Cerebellum: https://t.co/Wq6rzhTUl9

[Birgitt Schuele (She/her) @SchueleLab]

Exciting new study shows intermediate ATXN10 alleles in healthy Peruvian population. So much more to learn about repeat expansion disorders! https://t.co/3cwLW1moh0

[Birgitt Schuele (She/her) @SchueleLab]

Scrutinizing the KOLF2.1J iPSC line using @BionanoGenomics OGM. #OpenScience #iPSC #Genomics https://t.co/JLMqX3eiI3

[Birgitt Schuele (She/her) @SchueleLab]

Interested in joining our labs as a post-doc? @BrainResilience @StanfordPath @StanfordMed @Stanford_Neuro

[Birgitt Schuele (She/her) @SchueleLab]

We have an open position for a cell culture technician for an exciting new initiative to build a protein atlas for neurodegenerative diseases. Are you interested? Please see the link:
https://t.co/CIezaWG2dF

[Birgitt Schuele (She/her) @SchueleLab]

New Schuele lab Tee design. Any idea what we do?

[Ted Wilson @EdwardWilsonIII]

📣Please RT! Our lab @Stanford_Neuro has an immediate opening for a full-time Research Assistant studying biomarkers of neurodegenerative disease!
🔬🩸🥼

Fun & supportive training environment with fantastic colleagues!

For more info & to apply visit:
https://t.co/TMryiJtI9a

[Birgitt Schuele (She/her) @SchueleLab]

Looking forward to the Stem Cells in Neuroscience conference in Tuebingen next week! #StemCellTuebingen https://t.co/EWjga2Q4tS

[Birgitt Schuele (She/her) @SchueleLab]

Our Department of Pathology at Stanford University is seeking an exceptional scientist to join us as a tenure-line Assistant, Associate, or Full Professor.
@StanfordMed, @StanfordPath
Please share:
https://t.co/DvOIk8f3y6

[Birgitt Schuele (She/her) @SchueleLab]

Are you interested in publishing your latest research in the field of gene therapy for neurodegeneration with @SciReports? There is a new collection, we just launched.

[Birgitt Schuele (She/her) @SchueleLab]

Thanksgiving potluck luncheon in the Schuele lab!

[Birgitt Schuele (She/her) @SchueleLab]

We deposited a CRISPR-edited alpha-synuclein gene dosage human iPSC model with @officialatcc supported by @MichaelJFoxOrg. I hope this will be a valuable tool for #Parkinsons research community.

https://t.co/TX01yfxfkK

[Birgitt Schuele (She/her) @SchueleLab]

If you attend #Sfn23, check out our poster on multiplex imaging of human post-mortem brain, LRRK2, Parkinson’s disease in collaboration with @AkoyaBio and supported by @MichaelJFoxOrg

[Akoya Biosciences @AkoyaBio]

Attending #SfN23? Don’t miss our posters on how our #spatialphenotyping solutions contribute to the progress in #glioblastoma & #Parkinsonsdisease research.

#SfN2023 @SfNtweets @OracleBio @abcam @Stanford @StJude @AdityaPratapa_ @Theo_BrainC_lab @TheDohertyInst @SchueleLab

[Birgitt Schuele (She/her) @SchueleLab]

Congratulations to Ale Morato Torres for winning a poster prize at the Stanford Pathology retreat @StanfordPath for her in vivo work - knockdown of human alpha-synuclein as a therapeutic strategy.

[The Science of Parkinson's @ScienceofPD]

New research from @DanutaSastre @SchueleLab & @StanfordMed colleagues provides proof-of-concept in vitro targeting of the SNCA gene promoter using a #CRISPR interference (CRISPRi) system to controllably repress #Parkinsons-associated alpha-synuclein
https://t.co/8LUjk1zhH8

[Birgitt Schuele (She/her) @SchueleLab]

The journey has an end! Thanks for everyone who supported this study! It could have been a lot easier and faster, if we can all focus on the science! https://t.co/WpJugSyfum

[Dr Charlie Gardner (also on the blue place) @CharlieJGardner]

Happy 111th birthday to this little one

[Danuta Sastre 🔬🧬 @DanutaSastre]

My postdoc work is finally out! We used #CRISPR to lower alpha-synuclein in #Parkinsons #iPSC neurons, achieving functional recovery. #invivo work coming out soon from the team at @SchueleLab @StanfordMed pre-print here while in #PeerReview https://t.co/UjUwBSLsti